Critical factors to be considered when testing nanomaterials for genotoxicity with the comet assay.

The comet assay is widely used to test the genotoxicity of engineered nanomaterials (ENMs) but outcomes may vary when results from different laboratories, or even within one laboratory, are compared. We address some basic methodological considerations, such as the importance of carrying out physico-chemical characterisation of the ENMs in test-medium, performing uptake and cytotoxicity tests, and testing several genotoxicity-related endpoints. In this commentary, we discuss the different ways in which concentration of ENMs can be expressed, and stress the need to include appropriate controls and reference standards to monitor variation and avoid interference. Treatment conditions, including cell number, cell culture plate format and volume of treatment medium on the plate are crucial factors that may impact on results and thus should be kept constant within the study.

[1]  Vladimir Murashov,et al.  Adverse Effects of Engineered Nanomaterials Exposure, Toxicology, and Impact on Human Health , 2013 .

[2]  Maria Dusinska,et al.  Iron oxide nanoparticle toxicity testing using high-throughput analysis and high-content imaging , 2015, Nanotoxicology.

[3]  H. Karlsson,et al.  The comet assay in nanotoxicology research , 2010, Analytical and bioanalytical chemistry.

[4]  Matthew Boyles,et al.  Is the toxic potential of nanosilver dependent on its size? , 2014, Particle and Fibre Toxicology.

[5]  Helinor Johnston,et al.  Development of in vitro systems for nanotoxicology: methodological considerations , 2009, Critical reviews in toxicology.

[6]  Maria Dusinska,et al.  Testing strategies for the safety of nanoparticles used in medical applications. , 2009, Nanomedicine.

[7]  Maria Dusinska,et al.  Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests , 2015, Nanotoxicology.

[8]  Maria Dusinska,et al.  Suitability of human and mammalian cells of different origin for the assessment of genotoxicity of metal and polymeric engineered nanoparticles , 2015, Nanotoxicology.

[9]  G. Jenkins,et al.  In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines , 2012, Mutation research.

[10]  G. Pojana,et al.  Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles , 2015, Nanotoxicology.

[11]  Maria Dusinska,et al.  Can Standard Genotoxicity Tests be Applied to Nanoparticles? , 2012, Journal of toxicology and environmental health. Part A.

[12]  Philip Demokritou,et al.  High-Throughput Screening Platform for Engineered Nanoparticle-Mediated Genotoxicity Using CometChip Technology , 2014, ACS nano.

[13]  M. Saunders,et al.  Critical Evaluation of Toxicity Tests , 2012 .

[14]  Maria Dusinska,et al.  Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles , 2014, Nanotoxicology.

[15]  Maria Dusinska,et al.  Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. , 2012, Journal of environmental monitoring : JEM.